Trump to pick Heidi Overton to lead the FDAnews2026-08-19T01:24:36+00:00August 19th, 2026|Endpoints News|
CSL calls Tavneos withdrawal in Europe a ‘significant headwind’ for salesnews2026-08-18T17:56:30+00:00August 18th, 2026|Endpoints News|
Trump is taking credit for lower list prices. But a Biden-era law did a lot of the heavy liftingnews2026-08-18T16:26:00+00:00August 18th, 2026|Endpoints News|
BioMarin does another small deal to get early-stage bone disease assetnews2026-08-18T15:02:50+00:00August 18th, 2026|Endpoints News|
Exclusive: Third death revealed in China’s popular but opaque trialsnews2026-08-18T14:25:50+00:00August 18th, 2026|Endpoints News|
Amylyx reports Phase 3 win for GLP-1 antagonist avexitide in post-bariatric hypoglycemianews2026-08-18T11:01:54+00:00August 18th, 2026|Endpoints News|
Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposurenews2026-08-18T07:00:16+00:00August 18th, 2026|Endpoints News|
AI will be better than doctors at some medical tasks, healthcare and VC experts predictnews2026-08-17T20:20:28+00:00August 17th, 2026|Endpoints News|
Drugmakers voice support of US probe into Germany’s drug pricing plansnews2026-08-17T17:28:00+00:00August 17th, 2026|Endpoints News|
